NeuroOne Medical Technologies (NASDAQ:NMTC) Posts Quarterly Earnings Results

NeuroOne Medical Technologies (NASDAQ:NMTC) announced its quarterly earnings results on Wednesday. The company reported $0.06 earnings per share for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative return on equity of 407.04% and a negative net margin of 356.76%.

NeuroOne Medical Technologies Stock Performance

Shares of NMTC remained flat at $1.12 during midday trading on Thursday. The stock had a trading volume of 88,105 shares, compared to its average volume of 259,154. NeuroOne Medical Technologies has a 12-month low of $0.55 and a 12-month high of $1.50. The firm has a market cap of $34.56 million, a price-to-earnings ratio of -2.43 and a beta of 0.48. The stock’s 50 day moving average is $0.95 and its 200-day moving average is $0.88.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.